The therapeutic adherence in psychotic patients;La adherencia al tratamiento de los pacientes psicóticos

Revista de Psiquiatria de la Facultad de Medicina de Barcelona

Volumn 29, Issue 4, 2002, Pages 232-238

  Cirici, Roser ^a  

^a NONE   (Spain)

Author keywords

Adherence; Medication Management Module; Relapse prevention; Schizophrenia

Indexed keywords

ARTICLE; HUMAN; MAJOR CLINICAL STUDY; PATIENT COMPLIANCE; PATIENT INFORMATION; PSYCHOSIS; PSYCHOTHERAPY; SCHIZOPHRENIA;

EID: 0036743239     PISSN: 02137429     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Bäumi J, Kissling W. Buttner P, y col. Informationszentrierte Patienten und Angehörigengruppen zur Compliancaverbesserung bei schizophrenen Psychosen. Vernhaltenstherapie 1993:3(suppl 1):1-96.
2. Cirici R, Obiols J. La terapia cognitivo-constructivista en el proceso de rehabilitación de la esquizofrenia. Rev Psiquiatría Fac Med Barna 1998;25(6):166-71.
3. Cirici R, García M, Obiols J. Estrategias para aumentar la competencia social de los pacientes que sufren esquizofrenia. Rev Psiquiatría Fac Med Barna 2001; 28(1):8-15.
4. Cirici R. Esquizofrènia o Śindrome de Kraepelin-Bleuler? Full Informatiu Col-legi Oficial de Psicòlegs de Catalunya 2002;143:2-4.
5. Colom F, Vieta E. Aspectos clave en el cumplimiento del tratamiento farmacológico. Interpsiquis, 2002; http//www.psiquiatria.com/articulos/trastorno_bipolar/3706/
6. Corrigan, Liberman RP, Engle JD. From non-compliance to collaboration in the treatment of schizophrenia. Hosp and com psychiatry 1990;41:1203-11.
7. Delaney C. Reducing recidivism: medication versus psychosocial rehabilitation. J Psychosoc Nurs Ment Helth Serv 1998;36(11):28-34.
8. Eckman TA, Liberman RP, Philipps CC. Teaching medication management skills to schizophrenic patients. Journal of Clinical Psychopharmacology 1990;10(1):33-8.
9. Fenton WS, Blyler CR, Heinssen RK. Determinants of Medication Compliance in Schizophrenia: Empirical and Clinical Findings. Schizophrenia Bulletin 1997; 23(4):637-51.
10. Gaebel W, Pietzcker A. Indikation zur neuroleptischen Langseitmedikation-Standarderfahren oder individual-prognostisch geleitete Intervention? Nervenarzt 1983; 54:467-76.
11. Haynes RB, Sackett DL, Taylor DW (eds). Compliance in Health Care. Baltimore, MD: Johns Hopkins University Press, 1979.
12. Healey A, Knapp M, Astin J, Beecham J, Kemp R, Kirov G, David A Cost-effectiveness evaluation of compliance therapy for people with psychosis. Br J Psychiatry 1998;172:420-4.
13. Hogarty GE, Goldberg SC, Collaborative Study Group Drug and sociotherapy in the aftercare of schizophrenic patients: one-year relapse rates. Arch Gen Psychiatry 1974;28:54-64.
14. Kane JM. Compliance Issues in Outpatient Treatment. J Clin Psychopharmacology 1985;5(suppl 3):22-7.
15. Kelly J El impacto de la Medicación Antipsicótica: Estudio de Actitudes y Percepciones. En: Notas de prensa: Rev Psiquatría Fac Med Barna 1998;25(7):222-3.
16. Kemp R, Kirov G, Everitt B, Hayward P, David A Randomised controlled trial of compliance therapy. Br J Psychiatry 1998;172:413-9.
17. Kissling W, ed. Guidelines for neuroleptic relapse prevention in schizophrenia. Berlin: Springer-Verlag, 1991.
18. Kissling W. Ideal and Reality of Neuroleptic Relapse Prevention. Br J Psychiatry 1992;161(suppl. 18):133-9.
19. Kissling W. Compliance, quality assurance and standards for relapse prevention in schizophrenia. Acta Psychiatr Scand 1994:89(suppl 382):16-24.
20. Leff J, Wing JK. Trial of maintenance therapy in schizophrenia. Br Med J 1971;3:559-604.
21. Liberman RP Wallace CJ, Blackwell G, Kopelowicz A, Vaccaro JV, Mintz J. Skills Training Versus Psychosocial Occupational Therapy for Persons with Persistent Schizophrenia. Am J Psychiatry 1998;155(8):1087-91.
22. Marti MH. Una buena comunicación médico-paciente reduce el dolor crónico hasta el 20%. http://www.elpais.es/suple/articul⋯rint, 2002.
23. Navarro J (coord). I. El cumplimiento terapéutico. Manuales de referencia en atención primaria. Madrid: Doyma, 1999.
24. Somorza-Lennon M, Dixon L, Weiden P. Medication Compliance Among the Homeless Mentally III. Annual Meeting of the American Psychiatric Association, Washington DC, Mayo, 1992.
25. Trochinsky CH, Aaronson HG, Stone RK Maintenance phenothiazine in the aftercare of schizophrenic patients. Pennsylvania Psychiatric Q 1962;2:11-5.
26. US Health & Human Services. Adherence to Potent Antiretroviral Therapy. http://www.medscape.com/govmt/DHHS/guidelines/HIV/hiva/HIVa-O2.html. 1999.
27. Weiden Rapkin B, Mott T, Zygmunt A, Goldman D, HorvitzLennon, Frances A Rating of Medication Influences (ROMI). Scale in Schizophrenia. Schizophrenia Bull 1994;20(2):297-310.
28. Williams CT, Beese A. Schizophrenia Sufferers Health Beliefs and Compliance with Treatment. The International Society for the Psychological Treatments of the Schizophrenias anc other Psychosis ISPS, Londres, 12-17 Octubre de 1997.
29. Zarate R, Kopelowicz A. Módulos para el adiestramiento en habilidades sociales y para vivir de forma independiente (UCLA). Conferencia. Círculo Equestre, Barcelona, 3 de Mayo de 1999.